Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

This study has been completed.
Sponsor:
Collaborator:
University of Texas
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000307
First received: September 20, 1999
Last updated: August 11, 2008
Last verified: August 2008
  Purpose

The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.


Condition Intervention Phase
Alcohol-Related Disorders
Cocaine-Related Disorders
Drug: Naltrexone
Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Verified abstinence from cocaine [ Time Frame: over the 12 weeks of study ] [ Designated as safety issue: No ]

Estimated Enrollment: 0
Study Start Date: April 2003
Study Completion Date: April 2007
Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000307

Locations
United States, Texas
University of Texas Health Science Center
Houston, Texas, United States, 77225
Sponsors and Collaborators
University of Texas
Investigators
Principal Investigator: John Grabowski, Ph.D. University of Texas
  More Information

No publications provided

Responsible Party: Joy Schmitz, Ph.D., University of Texas Medical School at Houston
ClinicalTrials.gov Identifier: NCT00000307     History of Changes
Other Study ID Numbers: NIDA-09262-4, P50-09262-4
Study First Received: September 20, 1999
Last Updated: August 11, 2008
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Alcohol-Related Disorders
Cocaine-Related Disorders
Disease
Chemically-Induced Disorders
Mental Disorders
Pathologic Processes
Substance-Related Disorders
Naltrexone
Central Nervous System Agents
Narcotic Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on October 20, 2014